Thus they hypothesize that activated B cells migrate into the striated ducts in the SGs of patients with SS, irrespective of BCR specificity, while transformation to pathogenic RF expressing B cells is the result of lymphoma driver mutations acquisition, under the effect of the stimulatory environment of the striated duct [81,83]. This evidence concerns the gene BCR and synovial sarcoma.